Answers are grounded in this paper and cite their sources.
The main issues with drug safety in the counterfeit medicine supply chain, are to do with how the drugs are initially manufactured. The traceability of right and active pharmaceutical ingredients during actual manufacture is a difficult process, so detecting drugs that do not contain the intended active ingredients can ultimately lead to end-consumer patient harm or even death. Blockchain's advanced features make it capable of providing a basis for complete traceability of drugs, from manufacturer to end consumer, and the ability to identify counterfeit-drug. This paper aims to address the issue of drug safety using Blockchain and encrypted QR(quick response) code security.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: